Filter
2112
Filtered Results: 2112
Text search:
infect
drug
use
Featured
Recommendations
212
New Publications
468
Language
Document type
No document type
1232
Studies & Reports
347
Guidelines
316
Manuals
80
Strategic & Response Plan
51
Fact sheets
37
Training Material
26
Infographics
9
Situation Updates
8
Brochures
4
Resource Platforms
2
Countries / Regions
India
88
Kenya
54
Global
54
South Africa
52
Western and Central Europe
49
Tanzania
45
Nepal
44
Ukraine
37
Latin America and the Carribbean
32
Eastern Europe
30
Nigeria
28
Ethiopia
28
Russia
27
Myanmar / Burma
27
Uganda
25
Africa
24
Asia
24
Zambia
24
Brazil
23
Sierra Leone
22
Malawi
19
Liberia
19
Ghana
17
Philippines
16
Bangladesh
16
Namibia
14
Germany
13
South–East Asia Region
13
Rwanda
12
Mozambique
12
Colombia
10
Albania
9
Senegal
9
Indonesia
9
Lesotho
8
Cambodia
8
Tajikistan
7
Burkina Faso
7
Congo, Democratic Republic of
7
Georgia
7
Zimbabwe
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Botswana
6
Cameroon
5
Venezuela
5
East and Southern Africa
5
Argentina
5
Moldova
5
South Sudan
5
Eswatini/ Swaziland
5
Pakistan
5
North Macedonia
4
Thailand
4
Syria
4
Estonia
4
Peru
4
Benin
3
China
3
USA
3
Haiti
3
Guinea-Bissau
3
Paraguay
3
North America
3
Bolivia
3
Vietnam
3
Yemen
3
Mali
3
Angola
3
Mexico
2
Serbia
2
Turkey
2
Laos
2
Guinea
2
Jordan
2
Uruguay
2
France
2
Spain
2
Papua New Guinea
2
Sudan
2
Honduras
2
Ecuador
2
Switzerland
1
El Salvador
1
Gambia
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Afghanistan
1
Western Pacific Region
1
Jamaica
1
Belgium
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Sri Lanka
1
Egypt
1
Romania
1
Poland
1
Chad
1
Libya
1
Bhutan
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
628
Clinical Guidelines
234
Public Health
79
Women & Child Health
52
Key Resources
35
Pharmacy & Technologies
27
Capacity Building
22
Toolboxes
HIV
492
TB
280
NTDs
138
COVID-19
129
AMR
118
Mental Health
79
Rapid Response
46
Pharmacy
37
Ebola & Marburg
35
Refugee
33
Caregiver
27
Planetary Health
27
NCDs
16
Health Financing Toolbox
13
Zika
12
Polio
12
Global Health Education
11
Conflict
10
Cholera
7
Malaria
6
Specific Hazards
5
Natural Hazards
4
Disability
3
Social Ethics
2
Tsetse traps and targets (insecticide-impregnated screens) function by attracting the flies to a device that collects and/or kills them. Traps can be used for entomological surveillance, and also for control. Targets are simpler than traps, but are not used for surveillance. They are impregnated wit...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Tropical Medicine and Infectious Disease 2017, 2(4), 50
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige...
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
